Samuel A. Shelburne

Best Publications

• Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

  V. Gopalakrishnan;V. Gopalakrishnan;C. N. Spencer;C. N. Spencer;L. Nezi;A. Reuben

  4653
  Citations

• Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy

  Samuel A. Shelburne;Fehmida Visnegarwala;Jorge Darcourt;Edward A. Graviss

  829
  Citations

• Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy.

  Samuel A. Shelburne;Richard J. Hamill;Maria C. Rodriguez-Barradas;Stephen B. Greenberg

  732
  Citations

• The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy.

  Samuel A. Shelburne;Jorge Darcourt;A. Clinton White;Stephen B. Greenberg

  385
  Citations

• Immune reconstitution inflammatory syndrome: More answers, more questions

  Samuel A. Shelburne;Martin Montes;Richard J. Hamill;Richard J. Hamill

  371
  Citations

• The immune reconstitution inflammatory syndrome.

  Samuel A. Shelburne;Richard J. Hamill;Richard J. Hamill

  332
  Citations

• A direct link between carbohydrate utilization and virulence in the major human pathogen group A Streptococcus.

  Samuel A. Iii. Shelburne;David Keith;Nicola Horstmann;Paul Sumby

  231
  Citations

• Community‐Associated Strains of Methicillin‐Resistant Staphylococccus aureus as the Cause of Healthcare‐Associated Infection

  Blanca E. Gonzalez;Adriana M. Rueda;Samuel A. Shelburne;Daniel M. Musher

  228
  Citations

• The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia

  Jessica R. Galloway-Peña;Daniel P. Smith;Pranoti Sahasrabhojane;Nadim J. Ajami

  180
  Citations

• Streptococcus mitis strains causing severe clinical disease in cancer patients.

  Samuel A. Shelburne;Pranoti Sahasrabhojane;Miguel Saldana;Hui Yao

  165
  Citations

• The role of complex carbohydrate catabolism in the pathogenesis of invasive streptococci

  Samuel A. Shelburne;Michael T. Davenport;David B. Keith;James M. Musser

  158
  Citations

• Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa.

  Jose M. Munita;Samuel L. Aitken;William R. Miller;Federico Perez

  150
  Citations

• CovS simultaneously activates and inhibits the CovR-mediated repression of distinct subsets of group A Streptococcus virulence factor-encoding genes.

  Jeanette Treviño;Nataly Perez;Esmeralda Ramirez-Peña;Zhuyun Liu

  145
  Citations

• Clinical challenges treating Stenotrophomonas maltophilia infections: an update.

  Unknown

  144
  Citations

• Molecular mechanisms underlying group A streptococcal pathogenesis

  Randall J. Olsen;Samuel A. Shelburne;James M. Musser

  135
  Citations

• A decade of molecular pathogenomic analysis of group A Streptococcus

  James M. Musser;Samuel A. Shelburne

  126
  Citations

• Gut Microbiome Signatures Are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia

  Jessica R Galloway-Peña;Yushu Shi;Christine B Peterson;Pranoti Sahasrabhojane

  120
  Citations

• Oral step-down therapy is comparable to intravenous therapy for Staphylococcus aureus osteomyelitis.

  Naval G. Daver;Samuel A. Shelburne;Robert L. Atmar;Thomas P. Giordano

  120
  Citations

• Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients.

  Jessica R. Galloway-Peña;Daniel P. Smith;Pranoti Sahasrabhojane;W. Duncan Wadsworth

  118
  Citations

• Outcomes of treatment for hematogenous Staphylococcus aureus vertebral osteomyelitis in the MRSA ERA.

  Daniel J. Livorsi;Naval G. Daver;Robert L. Atmar;Samuel A. Shelburne

  112
  Citations